PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-58.66%
Negative revenue growth while 5715.T stands at 2.49%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-57.94%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-108.34%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-113.57%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-105.56%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-105.56%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-105.56%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.70%
10Y revenue/share CAGR under 50% of 5715.T's 38.93%. Michael Burry would suspect a lasting competitive disadvantage.
90.15%
5Y revenue/share CAGR above 1.5x 5715.T's 30.17%. David Dodd would look for consistent product or market expansions fueling outperformance.
18.56%
3Y revenue/share CAGR above 1.5x 5715.T's 6.30%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
90.57%
Below 50% of 5715.T's 5360.62%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
77.57%
5Y net income/share CAGR at 75-90% of 5715.T's 93.56%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
76.53%
Positive short-term CAGR while 5715.T is negative. John Neff would see a clear advantage in near-term profit trajectory.
406.76%
10Y equity/share CAGR above 1.5x 5715.T's 109.14%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
64.03%
5Y equity/share CAGR 1.25-1.5x 5715.T's 48.79%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
17.57%
3Y equity/share CAGR 1.25-1.5x 5715.T's 14.89%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-5.79%
Firm’s AR is declining while 5715.T shows 1.48%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-7.37%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-6.91%
Negative asset growth while 5715.T invests at 3.34%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.44%
BV/share growth above 1.5x 5715.T's 0.22%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-17.47%
We’re deleveraging while 5715.T stands at 5.65%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-19.85%
Our R&D shrinks while 5715.T invests at 82.35%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
2.44%
SG&A growth well above 5715.T's 1.67%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.